Reactive oxygen species: Modulators of phenotypic switch of vascular smooth muscle cells

dc.contributor.authorBadran, Adnan
dc.contributor.authorNasser, Suzanne A.
dc.contributor.authorMesmar, Joelle Edward
dc.contributor.authorEl-Yazbi, Ahmed F.
dc.contributor.authorBitto, Alessandra
dc.contributor.authorFardoun, Manal Muin
dc.contributor.authorBaydoun, Elias Abdel Hasan
dc.contributor.authorEid, Ali H.
dc.contributor.departmentDepartment of Biology
dc.contributor.departmentPharmacology and Toxicology
dc.contributor.facultyFaculty of Arts and Sciences (FAS)
dc.contributor.facultyFaculty of Medicine (FM)
dc.contributor.institutionAmerican University of Beirut
dc.date.accessioned2025-01-24T11:20:52Z
dc.date.available2025-01-24T11:20:52Z
dc.date.issued2020
dc.description.abstractReactive oxygen species (ROS) are natural byproducts of oxygen metabolism in the cell. At physiological levels, they play a vital role in cell signaling. However, high ROS levels cause oxidative stress, which is implicated in cardiovascular diseases (CVD) such as atherosclerosis, hypertension, and restenosis after angioplasty. Despite the great amount of research conducted to identify the role of ROS in CVD, the image is still far from being complete. A common event in CVD pathophysiology is the switch of vascular smooth muscle cells (VSMCs) from a contractile to a synthetic phenotype. Interestingly, oxidative stress is a major contributor to this phenotypic switch. In this review, we focus on the effect of ROS on the hallmarks of VSMC phenotypic switch, particularly proliferation and migration. In addition, we speculate on the underlying molecular mechanisms of these cellular events. Along these lines, the impact of ROS on the expression of contractile markers of VSMCs is discussed in depth. We conclude by commenting on the efficiency of antioxidants as CVD therapies. © 2020 by the authors. Licensee MDPI, Basel, Switzerland.
dc.identifier.doihttps://doi.org/10.3390/ijms21228764
dc.identifier.eid2-s2.0-85096333211
dc.identifier.pmid33233489
dc.identifier.urihttp://hdl.handle.net/10938/25157
dc.language.isoen
dc.publisherMDPI AG
dc.relation.ispartofInternational Journal of Molecular Sciences
dc.sourceScopus
dc.subjectCardiovascular disease
dc.subjectPhenotypic switch
dc.subjectReactive oxygen species
dc.subjectVascular smooth muscle cell
dc.subjectAngiotensin ii
dc.subjectAntioxidants
dc.subjectAtherosclerosis
dc.subjectBiomarkers
dc.subjectCardiovascular agents
dc.subjectCell cycle proteins
dc.subjectCell movement
dc.subjectCell proliferation
dc.subjectFibroblast growth factors
dc.subjectGene expression regulation
dc.subjectGraft occlusion, vascular
dc.subjectHumans
dc.subjectHypertension
dc.subjectMuscle, smooth, vascular
dc.subjectMyocytes, smooth muscle
dc.subjectNadph oxidases
dc.subjectOxidative stress
dc.subjectPhenotype
dc.subjectSignal transduction
dc.subjectReactive oxygen metabolite
dc.subjectAntioxidant
dc.subjectBiological marker
dc.subjectCardiovascular agent
dc.subjectCell cycle protein
dc.subjectFibroblast growth factor
dc.subjectReduced nicotinamide adenine dinucleotide phosphate oxidase
dc.subjectAngioplasty
dc.subjectCell cycle
dc.subjectCell differentiation
dc.subjectCell fate
dc.subjectCell migration
dc.subjectEpigenetics
dc.subjectHuman
dc.subjectMolecular mechanics
dc.subjectPathophysiology
dc.subjectProtein expression
dc.subjectRestenosis
dc.subjectReview
dc.subjectCell motion
dc.subjectDrug effect
dc.subjectGenetics
dc.subjectGraft occlusion
dc.subjectMetabolism
dc.subjectPathology
dc.subjectSmooth muscle cell
dc.subjectVascular smooth muscle
dc.titleReactive oxygen species: Modulators of phenotypic switch of vascular smooth muscle cells
dc.typeReview

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
2020-6471.pdf
Size:
10.31 MB
Format:
Adobe Portable Document Format